Related Experiment Video
Updated: Aug 8, 2026

Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
A macrophage-derived factor induced by alpha 1-acid glycoprotein that inhibits IL-1 comitogenic activity
P N Bories1, E Kodari, J Feger
1Laboratoire de Biochimie, Université Paris-Sud, Châtenay, Malabry, France.
Insights
Macrophages release an inhibitor of interleukin-1 (IL-1) after exposure to a specific alpha 1-acid glycoprotein (AGP) variant. This inhibitor modulates IL-1 activity, impacting thymocyte proliferation but not IL-2, TNF-alpha, or IL-6.
Area of Science:
- Immunology
- Biochemistry
Background:
- Alpha 1-acid glycoprotein (AGP) is involved in immune responses.
- Interleukin-1 (IL-1) plays a crucial role in inflammation and immune cell proliferation.
Purpose of the Study:
- To investigate the effect of a concanavalin A (Con A)-unreactive AGP variant on macrophage activity.
- To characterize the inhibitor of IL-1 proliferative activity released by macrophages.
Main Methods:
- Macrophage supernatant assay with thymocyte comitogenic assay.
- Physicochemical characterization including heat resistance, dialyzability, and size exclusion chromatography (Sephacryl S-200).
- Testing inhibitor's effect on murine and human recombinant IL-1, IL-2, TNF-alpha, and IL-6 activities.
Main Results:
- Macrophage supernatants from AGP-exposed cells inhibited IL-1 proliferative activity.
- The inhibitor was partially heat-resistant, undialyzable, and had an apparent molecular mass of 50-100 kDa.
- The inhibitor specifically affected IL-1 activity, with no significant impact on IL-2, TNF-alpha, or IL-6.
Conclusions:
- A Con A-unreactive AGP variant induces macrophages to release an IL-1 inhibitor.
- This inhibitor specifically targets IL-1 activity, suggesting a role for AGP in immune modulation.
Abstract:
After exposure to a concanavalin A (Con A)-unreactive variant of alpha 1-acid glycoprotein (AGP), macrophages released an inhibitor of interleukin-1 (IL-1) proliferative activity in the thymocyte comitogenic assay. This effect was observed with AGP concentrations above 100 micrograms/ml in the macrophage supernatant and would appear to be mediated by the macrophages, since native AGP had no activity on thymocyte proliferation. Preliminary physicochemical characterization showed that the factor was partially resistant to heating, undialyzable, and eluted with an apparent molecular mass of 50-100 kDa when subjected to Sephacryl S-200 chromatography. Murine IL-1 and human (h) recombinant (r) IL-1 were affected by this factor to the same extent. IL-1 and IL-2 co-induced thymocyte proliferation, which is mitogen-independent, was also inhibited, whereas hrIL-2 activity was not suppressed when assayed in thymocytes with PHA at a submitogenic concentration or in CTLL cells. The factor did not interfere with TNF alpha or hrIL-6 activity when tested against their specific cell line. These data indicate that the inhibitor may act specifically against IL-1 activity and further elucidate the possible role of AGP in the modulation of IL-1 activity via the secretion of an inhibitor.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Inflammation: Introduction

